Virtual Didactic - Chemotherapy Induced Peripheral Neuropathy presented by Katherine Power, MD-Chemotherapy Induced Peripheral Neuropathy Led by Katherine Power, MD

Video Transcription

Video Summary

During the video, Dr. Power discusses chemotherapy-induced peripheral neuropathy (CIPN), a common side effect of chemotherapy that affects the peripheral nerves. CIPN can lead to symptoms such as tingling, numbness, burning, and pain in the hands and feet. The severity of symptoms can vary from person to person and can impact their daily activities and quality of life. Risk factors for CIPN include older age, pre-existing neuropathy, certain medical conditions (diabetes, alcoholism, HIV), and specific chemotherapy agents. <br /><br />Dr. Power explains that there is no gold standard for diagnosing CIPN and treatment is primarily focused on managing symptoms. Medications such as duloxetine, pregabalin, gabapentin, and tricyclic antidepressants can be used to treat the positive symptoms of CIPN. Non-pharmacological treatments such as physical therapy, exercise, and neurostimulation therapy may also be beneficial. Dr. Power highlights the importance of assessing the patient's functional deficits, including balance and gait, and providing appropriate interventions for these impairments. She advises that regular physical exercise can help to lessen the severity of CIPN symptoms and recommends following exercise guidelines for cancer patients.<br /><br />Dr. Power also discusses several potential prevention strategies for CIPN, such as vitamin E supplementation, calcium and magnesium supplements, and alpha-lipoic acid, but notes that there is limited evidence to support their effectiveness. She emphasizes the importance of individualizing treatment and management plans based on the patient's specific symptoms and circumstances.<br /><br />The video presentation is provided by Dr. Power and was summarized by an AI assistant.

Keywords

chemotherapy-induced peripheral neuropathy

CIPN

tingling

numbness

burning

pain

diagnosing CIPN

treatment options

prevention strategies